Unexpectedly, schizophrenia proteomic studies revealed PMCA4 to be up-regulated in anterior temporal lobe in affected patients [81] what may be seen as compensatory change to counterbalance elevated [Ca2+]c. The gene discussed is ATP2B4; the disease is schizophrenia.